Antazoline
|
WikiDoc Resources for Antazoline |
|
Articles |
|---|
|
Most recent articles on Antazoline |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Antazoline at Clinical Trials.gov Clinical Trials on Antazoline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Antazoline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Antazoline Discussion groups on Antazoline Patient Handouts on Antazoline Directions to Hospitals Treating Antazoline Risk calculators and risk factors for Antazoline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Antazoline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Antazoline is a 1st generation antihistamine that also anticholinergic properties used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.[1]
